Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Tissue Engineering

Adam Feinberg's Biography

Adam Feinberg, CTO and Co-founder, FluidForm Inc., Professor of Biomedical Engineering, Carnegie Mellon University

Dr. Adam Feinberg is Co-Founder and CTO of FluidForm Inc, a start-up company commercializing FRESH 3D bioprinting technology, and a Professor at Carnegie Mellon University in the departments of Biomedical Engineering and Materials Science & Engineering. He earned his BS in Materials Science & Engineering from Cornell University in 1999 with Co-op experience at Abiomed, Inc., working on total artificial hearts. He then earned his PhD in Biomedical Engineering from the University of Florida, focused on engineering cell-material interactions to prevent and enhance adhesion. This was followed by postdoctoral training at Harvard University, developing new biomaterials and stem cell-based cardiac tissue engineering strategies. Dr. Feinberg has co-authored over 50 peer-reviewed publications, holds over 20 US patents and patent applications and has received multiple honors including the NSF CAREER Award, the NIH Director’s New Innovator Award, and Fellow of the American Institute for Medical and Biological Engineering. A primary research focus is engineering extracellular matrix (ECM) protein scaffolds using advanced biomanufacturing and 3D bioprinting approaches for multiple applications including cancer models, regenerative scaffolds, skeletal muscle and cardiac muscle tissue engineering. At FluidForm, he is driving the commercialization of the FRESH 3D bioprinting platform for a wide range of applications in the biopharma, medical device, and regenerative medicine industries.

Adam Feinberg Image

3D Printing Complex Biological Scaffolds using Freeform Reversible Embedding of Suspended Hydrogels (FRESH)

Friday, 18 March 2016 at 08:30

Add to Calendar ▼2016-03-18 08:30:002016-03-18 09:30:00Europe/London3D Printing Complex Biological Scaffolds using Freeform Reversible Embedding of Suspended Hydrogels (FRESH)

3D printing of hydrogels is an additive fabrication approach that has the potential to create complex construct architectures not possible using other tissue engineering methods. While there have been a number of advances, the 3D printing of soft hydrogels such as alginate, collagen and fibrin remains challenging because these materials typically have an elastic modulus <100 kPa and deform during the layer-by-layer printing process in air. To address this we have developed a Bingham plastic support bath into which these hydrogels can be printed with high fidelity and subsequently released, using a process we term freeform reversible embedding of suspended hydrogels (FRESH).

Add to Calendar ▼2016-03-17 00:00:002016-03-18 00:00:00Europe/LondonTissue